Approval · Notice of Compliance 24607 · 2020
LOLO: Notice of Compliance 24607
Issued November 17, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24607
- Date
- November 17, 2020
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes in the composition and manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOLO | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 10 MCG per TAB
- NORETHINDRONE ACETATE 1 MG per TAB